Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
GSK.GB | GSK plc | 49.9 | ¤79,666 | GB |
7741.JP | HOYA CORPORATION | 63.6 | ¤46,093 | JP |
4578.JP | Otsuka Holdings Co., Ltd. | 49.5 | ¤31,787 | JP |
068270.KR | Celltrion, Inc. | 35.6 | ¤28,453 | KR |
7733.JP | Olympus Corp. | 40.0 | ¤21,856 | JP |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
4552.JP | JCR Pharmaceuticals Co., Ltd. | 38.6 | ¤567 | JP |
COP.DE | CompuGroup Medical SE & Co. KGaA | 37.1 | ¤758 | DE |
3613.HK | Beijing Tong Ren Tang Chinese Medicine C | 34.8 | ¤863 | HK |
CVSG.GB | CVS Group plc | 35.2 | ¤905 | GB |
7071.JP | Amvis Holdings.Inc. | 74.9 | ¤1,240 | JP |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
4507.JP | Shionogi & Co., Ltd. | 48.9 | 20 | JP |
GSK.GB | GSK plc | 49.9 | 20 | GB |
IPN.FR | Ipsen SA | 65.0 | 18 | FR |
1093.HK | CSPC Pharmaceutical Group Limited | 53.6 | 16 | CN |
6849.JP | Nihon Kohden Corporation | 35.0 | 15 | JP |
4528.JP | ONO Pharmaceutical Co., Ltd. | 60.5 | 14 | JP |
4578.JP | Otsuka Holdings Co., Ltd. | 49.5 | 14 | JP |
7741.JP | HOYA CORPORATION | 63.6 | 13 | JP |
4516.JP | Nippon Shinyaku Co., Ltd. | 70.4 | 10 | JP |
SFZN.CH | Siegfried Holding AG | 58.5 | 9 | CH |
Average Market Cap | ¤0 |
Median Market Cap | ¤0 |
Avg. 3 Mo. Dollar Vol. | ¤0 |
Avg. 3 Mo. Trading Vol. | 0 |
Last Rebalance Date | N/A |
Companies Replaced | |
Biggest Increase | |
Biggest Decrease |
Trailing P/E Ratio (12 Mo.) | 0.0 |
Forward P/E Ratio (12 Mo.) | 0.0 |
Price/Book Ratio | 0.0 |
Avg. Revenue Chg. - 3 Yr | 0.0% |
Avg. Op. Income Chg. - 3 Yr. | 0.0% |
Avg. EPS Growth - 3 Yr. | 0.0% |
Avg. EPS Growth - 1 Yr. | 0.0% |
Avg. Operating Margin | 0.0% |
Avg. LT Debt to Total Capital | 0.0% |
Avg. Return on Equity | 0.0% |
Dividend Yield | 0% |
0.0 |
Japan | 46.67% |
Korea, Republic Of | 10.0% |
Taiwan, Province Of China | 6.67% |
United Kingdom | 6.67% |
Hong Kong | 6.67% |
Italy | 3.33% |
Switzerland | 3.33% |
China | 3.33% |
Germany | 3.33% |
Denmark | 3.33% |
Spain | 3.33% |
France | 3.33% |